Immunology (Biopharmaceutical Services)
Immunology (Biopharmaceutical Services) Companies (4)
Immunology (Biopharmaceutical Services) News
-
News Biogen acquires Apellis Pharmaceuticals to boost immunology and rare disease profile
Biogen Inc. has announced its acquisition of Apellis Pharmaceuticals, Inc., a move that is set to significantly enhance its growth portfolio in immunology and rare diseases. The agreement, valued at approximately US$5.6 billion, will see Biogen purchas... -
News BMS and Bain Capital Launch New Immunology-Focused Biotech
Bristol-Myers Squibb (BMS) and Bain Capital have established a new independent biopharmaceutical company focused on developing innovative therapies for autoimmune diseases, the companies announced on Monday.
-
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution
-
News NeoPhore Ltd. collaboration to continue exploring anti-tumour DNA mismatch repair inhibitors
NeoPhore Ltd. have entered a 3-year collaboration with leading cancer centre in New York, USA.
Immunology (Biopharmaceutical Services) Products (9)
-
Product RARE DISEASES & ORPHAN DRUGS
Lodaat has a portfolio pipeline of Rare Disease and Orphan Drug products. USFDA in development, we are looking for partners for the US, GCC, LATAM, EU markets. Many products are made in USA products in FDA approved facilities.
-
Product Surflo™ Winged Infusion Set with/without Needle Protection
Surflo™ Winged Infusion Sets with disposable infusion apparatus, are used for intravenous injection.
Surflo™ Winged Infusion Sets with needle protection (Surshield™) minimize the risk of accidental needle stick. Once activated, the needle is perman...
-
Product Novel Hyaluronidase (ALT-B4) Hybrozyme™
A novel and proprietary hyaluronidase to enable subcutaneous administration of IV biologics. Currently partnered with 4 global pharmaceutical companies including two Top 10 global pharmaceutical companies. ALT-B4 has enhanced thermal stability and protein stability leading to longer shelf-life, has higher ...
-
Product PEPperMAP® Epitope Mapping
Identify linear or conformational epitopes with amino acid resolution. Based on high-density peptide microarrays with linear or cyclic constrained peptides for conformational analyses, our PEPperMAP® Epitope Mapping Services enable the fingerprint analysis of antibody epitopes. Underlined by more than 2...
-
Product Anti-Drug Antibody Analysis
Protein or antibody drug immunogenicity results in the generation of anti-drug antibodies (ADAs), which can reduce drug efficacy, neutralize therapeutic effects or even cause severe immune adverse events to the patient. We provide the fingerprint analysis of anti-drug antibody responses on the epitope ...
-
Product PEPperCHIP® High-Density Peptide Microarrays
From single antigens to whole proteomes converted into overlapping peptides, or covering any epitope, peptide or antigen collection – PEPperCHIP® Custom Peptide Microarrays can be fully tailored in a uniquely fast and cost-effective manner with up to 25,000 peptides per glass slide – including non-natur...
-
Product Human Hepatitis B Immunoglobulin
The manufacturing process for human hepatitis B immunoglobulin contains a step of low pH incubation for viral inactivation. It contains a suitable amount of glycine as stabilizer, but does not contain any antiseptic or antibiotic.
Indications:
-Post-exposure prophylaxis should be c...
-
Product Human Hepstitis B Immunoglobulin (Ph4) For Intrevenous Injection
Major constituent: Human hepatitis B immunoglobulin; Subsidiary material: Maltose
Indications:Use of the product in combination with lamivudine can prevent patients with HBV (hepatitis B virus)-related diseases from being re-infected with HBV after liver transplantation.
Strengths:200...
Upcoming Events
-
CPHI & PMEC China 2026
Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026 -
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
08 Jul 2026 - 10 Jul 2026 -
CPHI Korea 2026
COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026

